Targeting of ibrutinib resistance–driving pathways by miR-28 in ABC-DLBCL
- DOI
- 10.1038/s41375-026-02948-9
- Published
- 2026-04-08
- Container
- Leukemia
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41375-026-02948-9,
title = {Targeting of ibrutinib resistance–driving pathways by miR-28 in ABC-DLBCL},
author = {Emigdio Álvarez-Corrales and Rocío Moreno-Palomares and Carmen Gómez-Escolar and Mario Martínez and Udane Moral-Pérez and María Laguna-Herrero and Teresa Fuertes and Belén S. Estrada and Sonia Mur and Adriana de Bonis and Magdalena Leiva and Nuria Martínez-Martín and Álvaro Somoza and Almudena R. Ramiro and Virginia G. de Yébenes},
year = {2026},
journal = {Leukemia},
doi = {10.1038/s41375-026-02948-9},
url = {https://doi.org/10.1038/s41375-026-02948-9}
}RIS
TY - JOUR TI - Targeting of ibrutinib resistance–driving pathways by miR-28 in ABC-DLBCL AU - Emigdio Álvarez-Corrales AU - Rocío Moreno-Palomares AU - Carmen Gómez-Escolar AU - Mario Martínez AU - Udane Moral-Pérez AU - María Laguna-Herrero AU - Teresa Fuertes AU - Belén S. Estrada AU - Sonia Mur AU - Adriana de Bonis AU - Magdalena Leiva AU - Nuria Martínez-Martín AU - Álvaro Somoza AU - Almudena R. Ramiro AU - Virginia G. de Yébenes PY - 2026 JO - Leukemia DO - 10.1038/s41375-026-02948-9 UR - https://doi.org/10.1038/s41375-026-02948-9 ER -
APA
Álvarez-Corrales, E., Moreno-Palomares, R., Gómez-Escolar, C., Martínez, M., Moral-Pérez, U., Laguna-Herrero, M., Fuertes, T., Estrada, B. S., Mur, S., Bonis, A. D., Leiva, M., Martínez-Martín, N., Somoza, Á., Ramiro, A. R., & Yébenes, V. G. D. (2026). Targeting of ibrutinib resistance–driving pathways by miR-28 in ABC-DLBCL. Leukemia. https://doi.org/10.1038/s41375-026-02948-9
Source records
- crossref · retrieved 2026-09-26T01:44:47.848Z